middle.news
Memphasys Gains Swift UK Traction with Felix™ System Trials and Early Orders
9:53am on Thursday 25th of June, 2026 AEST
•
Healthcare
Read Story
Memphasys Gains Swift UK Traction with Felix™ System Trials and Early Orders
9:53am on Thursday 25th of June, 2026 AEST
Key Points
Four UK IVF groups actively trial Felix™ System
Initial commercial orders received within weeks
UKCA Mark approval enables immediate UK market access
UK IVF market exceeds 100,000 annual cycles
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Memphasys (ASX:MEM)
OPEN ARTICLE